Measuring the endothelial function of Patients after COVID-19 Disease via retinal dynamic vessel analyzer

Measuring the endothelial function of Patients after COVID-19 Disease via retinal dynamic vessel analyzer - CORVAD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027891

Enrollment

Registered

2022-01-19

Start date

2020-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U09.9

Interventions

Group 1: Visit 1 - measurement of DVA, if pathologic control after 6, 12 weeks

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Long COVID Syndrom Minimum of 1 pos. PCR Test (Sars-CoV-19) before onset of symptoms

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Parameters of dynamic RVA are significantly reduced comapred to normal values.	—

Secondary

Measure	Time frame
Comparison of degree of symptoms (measured by EQ5D) verus lung function tests versus DVA Regression analysis with known cnonfounders (age, cardiovascular diesease, medications) Comparison of static vessel analyzer data versus normal collective subgroup analysis of regarding form of lung function abnormalities (Vascular vs interstitial vs normal)	—

Countries

Germany

Contacts

Public ContactRichard Biedermann

Uniklinikum Jena

richard.biedermann@med.uni-jena.de036419329631

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026